Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients: Relationship to glycemic control and coronary heart disease

Journal of Diabetes and its Complications

Volumn 18, Issue 5, 2004, Pages 258-263

  Smaoui, M ^a   Hammami, S ^b   Chaaba, R ^a   Attia, N ^a   Hamda, K Ben ^b   Masmoudi, A S ^a   Mahjoub, S ^b   Bousslama, A ^c   Farhat, M Ben ^b   Hammami, M ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Coronary heart disease; Lipid profile; Lipoprotein(a); Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; TUNISIA;

EID: 4444343642     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(03)00075-8     Document Type: Article

References (35)

1. Berg K. A new serum system in man: The Lp(a) system. Acta Pathologica et Microbiologica Scandinavica. 59:1963;369-382
2. Boewinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. Journal of Clinical Investigation. 90:1992;52-60
3. Cazzolato G., Prakash G., Green S., Kostner G.M. The determination of lipoprotein Lp(a) by rate endpoint nephelemetry. Clinica Chimica Acta. 135:1983;203
4. Chang C.J., Kao J.T., Wu T.J.W., Lu F.H., Tai T.Y. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Diabetes Care. 18:1995;1191-1194
5. Comlekci A., Biberoglu S., Kozan O., Bahceci O., Ergene O., Nazli C., Kinay O., Guner G. Correlation between serum lipoprotein(a) and angiographic coronary artery disease in non-insulin-dependent diabetes mellitus. Journal of Internal Medicine. 242:1997;449-454
6. Danesh J., Collins R., Peto R. Lipoprotein (a) and coronary heart disease: Meta-analysis of prospective studies. Circulation. 102:2000;1082-1085
7. De Man F.H., Caberzas M.C., Van Barlingen H.H., Erkelens D.W., de Bruin T.W. Triglyceride-rich lipoproteins in non-insulin-dependant diabetes mellitus: post-prandial metabolism and relation to premature atheosclerosis. European Journal of Clinical Investigation. 26:1996;89-108
8. Durlach V., Gillery P., Bertin E., Terpin J.M., Grulet H., Gross A., Leutenger M. Serum lipoprotein(a) concentrations in a population of 819 non-insulin-dependent diabetic patients. Diabete et Metabolisme. 22:1996;319-323
9. Erem C., Deger O., Bostan M., Orem A., Sonmez M., Ulusoy S., Telatar M. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Acta Cardiologica. 54:1999;203-207
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197
11. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 18:1972;499-502
12. Garg A., Grundy S.M. Management of dyslipidemia in NIDDM. Diabetes care. 13:1990;153-169
13. Gazzaruso C., Garzaniti A., Buscaglia P., D'Annunzio G., Porta A., Vandelli G., Lorini R., Finardi G., Fratino P., Geroldi D. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetologica. 35:1998;13-18
14. Gillery P., Arthuis P., Cuperlier C., Circaud R. A peak-rate nephelometric assay of serum lipoprotein(a). Clinical Chemistry. 39:1993;1122-1123
15. Gowri M.S., Westhuyzem D., Bridges S.R., Anderson J.W. Deceased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arteriosclerosis, Thrombosis, and Vascular Biology. 19:1999;2226-2233
16. Haffner S.M., Gruber K., Aldrete G., Tuttle K.T.R. Increased Lp(a) concentrations in renal failure. Journal of the American Society of Nephrology. 3:1992;1156-1162
17. Hayden J.M., Reaven P.S. Cardiovascular disease in diabetes mellitus type 2: A potential role for novel cardiovascular risk factors. Current Opinion in Lipidology. 11:2000;519-528
18. Hermandez C., Garcia-Pascual L., Chacon P., Simo R. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients. Diabetes Care. 24:2001;350-355
19. Howard B.V. Lipoprotein metabolism in diabetes mellitus. Journal of Lipid Research. 28:1978;613-628
20. Ihsibashi S. Lipoprotein(a) and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 21:2001;1-2
21. Kreisberg, R. A. (1998). Diabetic dyslipidemia. American Journal of Cardiology, 82, 67U-73U, 85U-86U.
22. Laakso M., Letho S. Epidemiology of macrovascular disease in diabetes. Diabetes Reviews. 5:1997;294-315
23. Maeda S., Abe A., Seishima M., Makino K., Noma A., Kawade M. Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis. 78:1989;145-150
24. Maher V.M.G., Brown B.G. lipoprotein(a) and coronary heart disease. Current Opinion in Lipidology. 6:2000;226-235
25. Mooser V., Schee D., Marcovina S.M., Wang J., Guerra R., Cohen J., Hobbs H.H. The apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. American Journal of Human Genetics. 61:1997;402-417
26. Paultre F., Pearson T.A., Weil H.F.C., Tuck C.H., Myerson M., Rubin J., Francis C.K., Marx H.F., Philbin E.F., Reed R.G., Berglund R.L. High levels of Lp(a) with a small Apo(a) isoform are associated with coronary artery disease in African American and White men. Arteriosclerosis, Thrombosis, and Vascular Biology. 20:2000;2619-2624
27. Rigla M., Sanchez-Quesada J.L., Ordonez-Llanos J., Prat T., Caixas A., Jorba O., Serra J.R., de Leiva A., Perez A. Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients. Metabolism. 49:2000;640-647
28. Sacks F.M., McPherson R., Walsh B.W. Effect of postmenopausal oestrogen replacement on plasma Lp(a) lipoprotein concentrations. Archives of Internal Medicine. 154:1994;1106-1110
29. Selvais Ph., Henrion J., Schapira G., Derue G., Hondekijin J.C., Parfonry A., Heller F.R. La lipoprotéine (a) dans les hépatopathics corrélation entre sa diminution et l'état fonctionnel du foic. Presse Médicale. 24:1995;382-386
30. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Archives of Internal Medicine. 157:1997;2413-2446
31. Song K.H., Ahn Y.B., Yoon K.H., Cha B.Y., Lee K.W., Son H.Y., Kang S.K. The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with type 2 diabetes mellitus. Diabetic Medicine. 16:1999;1036-1039
32. Tarkun I., Cetinarslan B., Canturk Z. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complication. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 12(3):2002;127-131
33. Taskinen M.R. Lipoprotein lipase in diabetes. Diabetes and Metabolism Review. 3:1987;551-570
34. Utermann G., Zeber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Letters. 154:1983;357-361
35. Ziegler O., Guerci B., Candiloros H., Drouin P. Lipoprotein (a) and diabetes mellitus. Diabete et Metabolisme (Paris). 21:1995;127-138